Promore – Reports and prospectus

Interim Reports (Promore) November 24, 2020 Delårsrapport januari – september 2020	Report (pdf)
Interim Reports (Promore) November 24, 2020 Interim report January – September 2020	Report (pdf)
Interim Reports (Promore) August 25, 2020 Promore Pharma AB (publ) Delårsrapport januari – juni 2020	Report (pdf)
Interim Reports (Promore) August 25, 2020 Promore Pharma AB (publ) Interim report January – June 2020	Report (pdf)
Interim Reports (Promore) May 26, 2020 Promore Pharma AB (publ) Delårsrapport januari – mars 2020	Report (pdf)
Interim Reports (Promore) May 26, 2020 Promore Pharma AB (publ) Interim report January – March 2020	Report (pdf)
Annual Reports (Promore) May 5, 2020 Årsredovisning 2019	Report (pdf)
Annual Reports (Promore) May 5, 2020 Annual Report 2019	Report (pdf)
Interim Reports (Promore) February 18, 2020 Promore Pharma AB (publ) Bokslutskommuniké 2019	Report (pdf)
Interim Reports (Promore) February 18, 2020 Promore Pharma AB (publ) Year-end report 2019	Report (pdf)

MESSAGE FROM THE CEO

Read what our CEO has to say about our business.

Read the CEO message

BUSINESS MODEL

The RespiraSense™ business model consists of several components that together create a complete delivery that generates attractive gross margins and recurring revenues.

Learn more about the business model

VISION

To avoid preventable respiratory failure events by transforming the standard of care in patient monitoring.

MISSION

To become the de facto standard-of-care for monitoring respiratory compromised patients in Europe and the US.